These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 3095772

  • 1. [In-vivo bacteriostatic and bactericidal activity of pefloxacine].
    Meyran M, Thabaut A.
    Pathol Biol (Paris); 1986 May; 34(5):349-52. PubMed ID: 3095772
    [Abstract] [Full Text] [Related]

  • 2. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
    Berardi-Grassias LD, Roy O.
    Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter].
    Berardi-Grassias L, Bigel ML, Macheboeuf F, Boisivon A, Chauvière P, Guiomar C.
    Pathol Biol (Paris); 1986 May; 34(5):436-9. PubMed ID: 3534716
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C, Saivin S, Lafferriere C, Noury P, Bebear C.
    Drugs Exp Clin Res; 1987 May; 13(4):219-24. PubMed ID: 3476291
    [Abstract] [Full Text] [Related]

  • 8. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ, Leclercq R, Duval J.
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [Abstract] [Full Text] [Related]

  • 9. [Pefloxacin: clinical experience].
    Bertrand A, Janbon F, Jourdan J, Jonquet O, Santoni A.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [Abstract] [Full Text] [Related]

  • 10. Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.
    Van der Auwera P, Husson M, Klastersky J.
    J Antimicrob Chemother; 1988 Jan; 21(1):49-55. PubMed ID: 3128521
    [Abstract] [Full Text] [Related]

  • 11. Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections.
    Boerema JB, Olthof BJ, van Saene HK.
    Scand J Infect Dis Suppl; 1986 Jan; 48():27-31. PubMed ID: 3095916
    [Abstract] [Full Text] [Related]

  • 12. [Antibacterial activity of urine after administration of ofloxacin for 5 days].
    Drugeon H, Veyries ML, Levacher M, Garnier M, Aymard G, Giroud JP, Rouveix B.
    Therapie; 2000 Jan; 55(6):691-7. PubMed ID: 11234464
    [Abstract] [Full Text] [Related]

  • 13. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H, Naber KG, Kinzig-Schippers M, Sörgel F, Rustige-Wiedemann C, Wiedemann B, Reiz A, Kresken M.
    Infection; 1997 Jan; 25(2):121-6. PubMed ID: 9108190
    [Abstract] [Full Text] [Related]

  • 14. Bacteriostatic activities in normal human serum against serologically classified Pseudomonas as aeruginosa from the urinary tract infection.
    Fujimura N, Yokoyama R.
    Tokushima J Exp Med; 1978 Dec; 25(3-4):87-90. PubMed ID: 111374
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical studies of norfloxacin in urinary tract infections].
    Matsuura T, Kurita T.
    Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
    [Abstract] [Full Text] [Related]

  • 16. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
    Quentin C, Noury P, Laurent C, Saivin S, Bebear C.
    Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
    [Abstract] [Full Text] [Related]

  • 17. Bactericidal effects of norfloxacin towards bacteria in urine.
    Lacey RW, Lord VL, Howson GL.
    J Antimicrob Chemother; 1984 May; 13 Suppl B():49-54. PubMed ID: 6234275
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ, Durgham SM, Shibl AM.
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F.
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [Abstract] [Full Text] [Related]

  • 20. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO, Izard D, Bryskier A, Leclerc H.
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.